Your browser doesn't support javascript.
loading
Comparison of conventional dose and double dose carboplatin in patients receiving cyclophosphamide plus carboplatin for advanced ovarian carcinoma: a North Central Cancer Treatment Group Study.
Edmonson, J H; Suman, V J; Dalton, R J; Bro, W C; Gallenberg, M M; Long, H J; Levitt, R; Hatfield, A K; Krook, J E; Mailliard, J A; Gerstner, J B.
Affiliation
  • Edmonson JH; Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA.
Cancer Invest ; 19(6): 597-602, 2001.
Article in En | MEDLINE | ID: mdl-11486702
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Recombinant Proteins / Antineoplastic Combined Chemotherapy Protocols / Carboplatin / Granulocyte-Macrophage Colony-Stimulating Factor Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Middle aged Country/Region as subject: America do norte Language: En Journal: Cancer Invest Year: 2001 Document type: Article Affiliation country: United States Country of publication: United kingdom
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Recombinant Proteins / Antineoplastic Combined Chemotherapy Protocols / Carboplatin / Granulocyte-Macrophage Colony-Stimulating Factor Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Middle aged Country/Region as subject: America do norte Language: En Journal: Cancer Invest Year: 2001 Document type: Article Affiliation country: United States Country of publication: United kingdom